Exploiting KRAS-driven Ferroaddiction in Cancer Through Ferrous Iron-Activatable Drug Conjugates (FeADC)

Honglin Jiang(University of California, San Francisco), Adam R. Renslo(University of California, San Francisco)
bioRxiv (Cold Spring Harbor Laboratory)
May 14, 2020
Cited by 2


Related Papers